Life Science Investing Arcturus Therapeutics Announces Third Quarter 2025 Financial Update and Pipeline Progress
Life Science Investing Arcturus Therapeutics to Report Third Quarter Financial Results and Provide Corporate Update on November 10, 2025
Life Science Investing Arcturus Therapeutics Provides Interim Phase 2 Data for Cystic Fibrosis Program
Life Science Investing Arcturus Therapeutics Announces Second Quarter 2025 Financial Update and Pipeline Progress
Nine Mile Metals Announces Completion of DDH WD-25-02B and Continues to Confirm Zones of Copper Rich VMS with 66 Meters of Mineralization at the Wedge Project
